Viewing Study NCT02723994

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 1:27 AM
Ignite Modification Date: 2026-02-21 @ 1:20 AM
Study NCT ID: NCT02723994
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-10-17
First Post: 2016-03-09
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: A Phase 2 Study of Ruxolitinib With Chemotherapy in Children With Acute Lymphoblastic Leukemia
Sponsor: Incyte Corporation
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Leukemia View
Keywords:

Keywords

Keyword Brief Keyword Text View
None B-cell acute lymphoblastic leukemia (ALL) View
None pediatric View
None multi-agent chemotherapy View
None JAK inhibitor View